I have the same mission as Benioff Children’s Hospital Oakland: to treat and improve the outcome for every child and family who comes here for care and support.
Where I see patients (2)
Selected research
-
Incremental eligibility criteria for the BMT CTN 1507 haploidentical trial for children with sickle cell disease.
Blood advances
-
Betibeglogene autotemcel gene therapy in patients with transfusion-dependent, severe genotype β-thalassaemia (HGB-212): a non-randomised, multicentre, single-arm, open-label, single-dose, phase 3 trial.
Lancet (London, England)
-
Hematopoietic Cell Transplant compared with Standard Care in Adolescents and Young Adults with Sickle Cell Disease.
Blood advances
Contact me
Learning never stops
Our classroom and bedside classes help kids get credit and keep learning during treatment.
See our school program